KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Share-based Compensation (2016 - 2025)

Jazz Pharmaceuticals has reported Share-based Compensation over the past 16 years, most recently at $70.9 million for Q4 2025.

  • Quarterly Share-based Compensation rose 0.95% to $70.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $291.1 million through Dec 2025, up 17.37% year-over-year, with the annual reading at $291.1 million for FY2025, 17.37% up from the prior year.
  • Share-based Compensation was $70.9 million for Q4 2025 at Jazz Pharmaceuticals, down from $88.1 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $88.1 million in Q3 2025 and troughed at $34.5 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $56.7 million (2022), against an average of $58.9 million.
  • Biggest five-year swings in Share-based Compensation: soared 75.38% in 2021 and later fell 14.0% in 2023.
  • Tracing JAZZ's Share-based Compensation over 5 years: stood at $53.1 million in 2021, then rose by 15.89% to $61.6 million in 2022, then dropped by 14.0% to $52.9 million in 2023, then soared by 32.58% to $70.2 million in 2024, then rose by 0.95% to $70.9 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $70.9 million, $88.1 million, and $64.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.